CK

Chandan Kumar Das

Active Director Designated Partner DIN 11891570
DIN 11891570 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandan Kumar Das

Chandan Kumar Das is a Designated Partner at Umananda Superspeciality Hospital Llp (since 2026).

DIN 11891570
Primary Designation Designated Partner
First Appointment 13 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Aug 20262026Active

Board colleagues of Chandan Kumar Das

Directorship timeline

Open interactive timeline →
Umananda Superspeciality Hospital Llp
Premium access

Shareholding and investment profile for Chandan Kumar Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandan Kumar Das

Chandan Kumar Das currently holds 1 directorship: Umananda Superspeciality Hospital Llp (Designated Partner, since 13 Aug 2026).

Chandan Kumar Das was first appointed on 13 Aug 2026 as Designated Partner at Umananda Superspeciality Hospital Llp.

The current boards of Chandan Kumar Das's companies include Amit Kumar Saha (Umananda Superspeciality Hospital Llp), Biplab Das (Umananda Superspeciality Hospital Llp), Chiranjit Sarkar (Umananda Superspeciality Hospital Llp), Nirav Agarwal (Umananda Superspeciality Hospital Llp), Sanjan Das (Umananda Superspeciality Hospital Llp), Uday Deka (Umananda Superspeciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available